{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T06:12:53Z","timestamp":1793686373680,"version":"4.5.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Thrombotic microangiopathies (TMAs) encompass a diverse group of syndromes marked by microvascular thrombosis, thrombocytopenia, and organ injury, primarily affecting the kidneys and central nervous system. While the etiologies differ\u2014ranging from genetic mutations to infectious and autoimmune triggers\u2014a unifying pathogenic mechanism is endothelial dysfunction. Recent advances have illuminated the pivotal role of cytokine dysregulation in initiating and sustaining this vascular injury. The release of pro-inflammatory cytokines such as TNF-\u03b1, IL-1\u03b2, and IL-6 creates a state of sustained endothelial activation that promotes leukocyte adhesion, vascular permeability, and a prothrombotic surface phenotype. In various TMA subtypes, the cytokine response acts as both a trigger and an amplifier of disease progression. In atypical hemolytic uremic syndrome (aHUS), cytokines are upregulated secondary to complement dysregulation, while in thrombotic thrombocytopenic purpura (TTP), inflammation may lower ADAMTS13 activity and potentiate thrombosis. Secondary TMAs, including those associated with autoimmune disease, pregnancy, and transplantation, often exhibit pronounced cytokine profiles that directly correlate with endothelial injury and clinical severity. These overlapping inflammatory signatures underscore the need to view TMAs not only through a hematologic or immunologic lens but also within the context of vascular inflammation.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003700","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T13:00:15Z","timestamp":1754744415000},"page":"5912-5917","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Cytokine storm and microvascular fate: mechanistic insights into endothelial injury in thrombotic microangiopathies"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe"},{"name":"Department of Medical Laboratory Science, Kampala International University, Ishaka, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/ijms25010047","article-title":"To gain insights into the pathophysiological mechanisms of the thrombo-inflammatory process in the atherosclerotic plaque","volume":"25","author":"Nappi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"9055","DOI":"10.3390\/ijms25169055","article-title":"The phenomenon of thrombotic microangiopathy in cancer patients","volume":"25","author":"Vorobev","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/diagnostics13071228","article-title":"Pitfalls of thrombotic microangiopathies in children: two case reports and literature review","volume":"13","author":"Mocanu","year":"2023","journal-title":"Diagnostics"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"A7544","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A7544","article-title":"Thrombosis meets cytokine surge: the perfect storm in catastrophic antiphospholipid syndrome","volume":"211","author":"Kcomt","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3390\/jcm13061598","article-title":"Thrombotic microangiopathy as a life-threatening complication of long-term interferon beta therapy for multiple sclerosis: clinical phenotype and response to treatment\u2014a literature review","volume":"13","author":"Allinovi","year":"2024","journal-title":"J Clin Med"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"e021428","DOI":"10.1161\/JAHA.121.021428","article-title":"Skewed cytokine responses rather than the magnitude of the cytokine storm may drive cardiac dysfunction in multisystem inflammatory syndrome in children","volume":"10","author":"Chang","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/ajh.26872","article-title":"Reeling in complement in transplant-associated thrombotic microangiopathy: you\u2019re going to need a bigger boat","volume":"98","author":"Jodele","year":"2023","journal-title":"Am J Hematol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/children10030506","article-title":"A fatal case of neuroblastoma complicated by posterior reversible encephalopathy with rapidly evolving transplantation-associated thrombotic microangiopathy","volume":"10","author":"Matsui","year":"2023","journal-title":"Children"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.jtct.2025.01.209","article-title":"The tell-tale heart: a cytokine storm story of pericardial effusions after HSCT","volume":"31","author":"Koo","year":"2025","journal-title":"Transplantation and Cellular Therapy"},{"key":"R10-20251007","first-page":"108\u201312","article-title":"Concurrent hemophagocytic lymphohistiocytosis and thrombotic microangiopathy in a patient with epstein-barr virus infection and gastric adenocarcinoma: the puzzle started with microangiopathic hemolytic anemia","volume":"36","author":"Zhou","year":"2025","journal-title":"Blood Coagul"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"57\u201360","DOI":"10.20344\/amp.21969","article-title":"Infection and immunosuppression as causes for immune dysfunction presenting as hemophagocytic lymphohistiocytosis and thrombotic microangiopathy","volume":"38","author":"Atalaia-Barbacena","year":"2025","journal-title":"Acta Med Port"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1681\/ASN.20223311S1384b","article-title":"Thrombotic microangiopathy associated with use of liposomal doxorubicin: FR-PO212","volume":"33","author":"Ornelas","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/medicina58091311","article-title":"Molecular pathogenesis of endotheliopathy and endotheliopathic syndromes, leading to inflammation and microthrombosis, and various hemostatic clinical phenotypes based on \u201ctwo-activation theory of the endothelium\u201d and \u201ctwo-path unifying theory\u201d of hemostasis","volume":"58","author":"Chang","year":"2022","journal-title":"Medicina (B Aires)"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"811504","DOI":"10.3389\/fmed.2022.811504","article-title":"Complement mediated endothelial damage in thrombotic microangiopathies","volume":"9","author":"Blasco","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"1088031","DOI":"10.3389\/fphar.2022.1088031","article-title":"Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management","volume":"13","author":"Mazzierli","year":"2023","journal-title":"Front Pharmacol"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"196\u2013202","DOI":"10.1016\/j.jpeds.2021.04.004","article-title":"Thrombotic microangiopathy associated with macrophage activation syndrome: a multinational study of 23 patients","volume":"235","author":"Minoia","year":"2021","journal-title":"J Pediatr"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"609\u201314","DOI":"10.1016\/j.medcle.2020.12.025","article-title":"Microvascular thrombosis and clinical implications","volume":"156","author":"Paramo","year":"2021","journal-title":"Medicina Cl\u00ednica (English Edition)"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"1055\u201366","DOI":"10.1093\/ckj\/sfaa195","article-title":"Thrombotic microangiopathies assessment: mind the complement","volume":"14","author":"Blasco","year":"2021","journal-title":"Clin. Kidney J"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"730\u201340","DOI":"10.3899\/jrheum.220752","article-title":"The role of complement in autoimmune disease-associated thrombotic microangiopathy and the potential for therapeutics","volume":"50","author":"Java","year":"2023","journal-title":"J Rheumatol"},{"key":"R20-20251007","first-page":"234","article-title":"Microvascular endothelial activation\/dysfunction and dysregulation of the angiopoietin-TIE2 system in the pathogenesis of life-threatening infections","volume":"133","author":"Liles","year":"2023","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"780107","DOI":"10.3389\/fimmu.2021.780107","article-title":"Thrombotic microangiopathy, an unusual form of monoclonal gammopathy of renal significance: report of 3 cases and literature review","volume":"12","author":"Filippone","year":"2021","journal-title":"Front Immunol"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"524","DOI":"10.23876\/j.krcp.22.010","article-title":"A new pathological perspective on thrombotic microangiopathy","volume":"41","author":"Kim","year":"2022","journal-title":"Kidney Res Clin Pract"},{"key":"R23-20251007","doi-asserted-by":"crossref","first-page":"543\u201353","DOI":"10.1038\/s41581-021-00424-4","article-title":"Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics","volume":"17","author":"Fakhouri","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"20543581211008707","DOI":"10.1177\/20543581211008707","article-title":"Making the correct diagnosis in thrombotic microangiopathy: a narrative review","volume":"8","author":"McFarlane","year":"2021","journal-title":"Can J Kidney Health Dis"},{"key":"R25-20251007","first-page":"11\u201323","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"100690","DOI":"10.1016\/j.modpat.2024.100690","article-title":"Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy","volume":"38","author":"van Doorn","year":"2025","journal-title":"Modern Pathol"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"90277","DOI":"10.5500\/wjt.v14.i1.90277","article-title":"Thrombotic microangiopathy after kidney transplantation: expanding etiologic and pathogenetic spectra","volume":"14","author":"Mubarak","year":"2024","journal-title":"World J Transplant"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"566678","DOI":"10.3389\/fmed.2021.566678","article-title":"Retrospective and systematic analysis of causes and outcomes of thrombotic microangiopathies in routine clinical practice: an 11-year study","volume":"8","author":"Henry","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"153\u201365","DOI":"10.1002\/art.42681","article-title":"Clinical evaluation and management of thrombotic microangiopathy","volume":"76","author":"Leisring","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"11287","DOI":"10.3390\/ijms241411287","article-title":"Coronary \u201cmicrovascular dysfunction\u201d: evolving understanding of pathophysiology, clinical implications, and potential therapeutics","volume":"24","author":"Kei","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R31-20251007","first-page":"6719\u201333","article-title":"Advances in research on the release of von willebrand factor from endothelial cells through the membrane attack complex C5b-9 in sepsis","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflamm Res"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/ijms25021082","article-title":"The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"2156\u201369","DOI":"10.2174\/1381612827666210303143442","article-title":"Chronic inflammation and cancer: the role of endothelial dysfunction and vascular inflammation","volume":"27","author":"Malhab","year":"2021","journal-title":"Curr Pharm Des"},{"key":"R34-20251007","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3390\/ijms23042106","article-title":"Proinflammatory cytokines (IL-1,-6,-8,-15,-17,-18,-23, TNF-\u03b1) single nucleotide polymorphisms in rheumatoid arthritis\u2014a literature review","volume":"23","author":"Koper-Lenkiewicz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1681\/ASN.20233411S1445b","article-title":"Successful management of TAFRO syndrome-related renal thrombotic microangiopathy with interleukin-6 inhibitor: FR-PO143","volume":"34","author":"Abdelkader","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"191\u2013203","DOI":"10.1080\/17474086.2023.2162501","article-title":"Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis","volume":"16","author":"Guo","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: a general approach to diagnosis and management","volume":"189","author":"Arnold","year":"2017","journal-title":"Cmaj"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"310596","DOI":"10.5402\/2012\/310596","article-title":"Thrombotic microangiopathies","volume":"2012","author":"Radhi","year":"2012","journal-title":"ISRN Hematol"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"10007","DOI":"10.3390\/ijms251810007","article-title":"Anti-inflammatory cytokine profiles in thrombotic thrombocytopenic purpura-differences compared to COVID-19","volume":"25","author":"Demeter","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R40-20251007","first-page":"649","article-title":"Cancer-associated thrombotic microangiopathy","volume":"10","author":"Govind Babu","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"R41-20251007","first-page":"8599\u2013609","article-title":"Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies","volume":"30","author":"Font","year":"2022","journal-title":"Support Care Cancer"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/toxins12020067","article-title":"Shiga toxin-associated hemolytic uremic syndrome: a narrative review","volume":"12","author":"Joseph","year":"2020","journal-title":"Toxins (Basel)"},{"key":"R43-20251007","doi-asserted-by":"crossref","first-page":"1595207","DOI":"10.3389\/fendo.2025.1595207","article-title":"New insights of potential biomarkers in diabetic retinopathy: integrated multi-omic analyses","volume":"16","author":"Wang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R44-20251007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40635-025-00766-4","article-title":"Advancing omics technologies in acute respiratory distress syndrome: paving the way for personalized medicine","volume":"13","author":"Al-Husinat","year":"2025","journal-title":"Intensive Care Med Exp"},{"key":"R45-20251007","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN Guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Premi J Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:03:52Z","timestamp":1759827832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003700","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2025-06-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}